Our Experts

Meet Your Care Team

Dr. Hasan Aahed Husni

Consultant Endocrinologist

stethoscope Endocrinology

work_history 10+ Years of Experience

Biography

Dr. Hasan Aahed Husni is a Consultant Endocrinologist with extensive clinical and academic expertise developed at premier medical institutions in the United States. Notably, he served as a Consultant Endocrinologist at the Cleveland Clinic in the U.S. His clinical interests include the management of metabolic bone diseases, osteoporosis, calcium and parathyroid disorders, and vitamin D deficiency, as well as diabetes, hypoglycemia disorders, and insulin pump management. He holds advanced medical qualifications, including American Board certifications in Endocrinology, Diabetes & Metabolism, Internal Medicine, and Obesity Medicine. He completed his specialized fellowship training at Johns Hopkins Hospital. Alongside his clinical practice, Dr. Hasan is deeply committed to medical education, having served in active roles supervising and mentoring residents and fellows, delivering educational lectures, and contributing to academic initiatives. In addition to his clinical work, he possesses a research background with multiple publications in peer-reviewed medical journals and contributions to scientific reviews and clinical guidance. This academic foundation reflects his dedicated commitment to providing evidence-based, patient-centered care.

Professional Profile.

  • Medical Student Teaching Award – Department of Medicine, May 2018
  • Patterns of osteoporosis medication selection after a drug holiday or continuation: a real-world experience. Endocrine Practice, October 2022; Vol. 28, Issue 10, pp. 1078–1085.
  • Cortisol values during standard-dose cosyntropin stimulation testing: a single-centre experience using the Elecsys Cortisol II assay. Frontiers in Endocrinology, August 2022.
  • The dural tail sign in meningiomas. AACE Clinical Case Reports, 2021.
  • A persistent cause of imbalance: thyroid-associated cerebellar ataxia. Cureus, May 2020.
  • Fracture risk assessment and drug holiday in real-world practice. Journal of Clinical Densitometry, January–March 2023.
  • Four strategies for diabetes management during Ramadan, March 2024.
  • Is religious fasting safe for patients with diabetes? March 2024.
  • Physical activity and exercise. Johns Hopkins Diabetes Guide, 2021.
  • Postdoctoral Fellowship in Endocrinology, Diabetes & Metabolic Disorders, Johns Hopkins Hospital, Baltimore, USA (2019–2021)
  • Internal Medicine Residency, John H. Stroger Jr. Hospital of Cook County, Chicago, USA (2016–2019)
  • Misr University for Science and Technology – Faculty of Medicine, Egypt (2007–2010)
  • University of Baghdad – Faculty of Medicine, Iraq (2003–2007)

  • Medical Student Teaching Award – Department of Medicine, May 2018

  • Patterns of osteoporosis medication selection after a drug holiday or continuation: a real-world experience. Endocrine Practice, October 2022; Vol. 28, Issue 10, pp. 1078–1085.
  • Cortisol values during standard-dose cosyntropin stimulation testing: a single-centre experience using the Elecsys Cortisol II assay. Frontiers in Endocrinology, August 2022.
  • The dural tail sign in meningiomas. AACE Clinical Case Reports, 2021.
  • A persistent cause of imbalance: thyroid-associated cerebellar ataxia. Cureus, May 2020.
  • Fracture risk assessment and drug holiday in real-world practice. Journal of Clinical Densitometry, January–March 2023.
  • Four strategies for diabetes management during Ramadan, March 2024.
  • Is religious fasting safe for patients with diabetes? March 2024.
  • Physical activity and exercise. Johns Hopkins Diabetes Guide, 2021.

  • Postdoctoral Fellowship in Endocrinology, Diabetes & Metabolic Disorders, Johns Hopkins Hospital, Baltimore, USA (2019–2021)
  • Internal Medicine Residency, John H. Stroger Jr. Hospital of Cook County, Chicago, USA (2016–2019)
  • Misr University for Science and Technology – Faculty of Medicine, Egypt (2007–2010)
  • University of Baghdad – Faculty of Medicine, Iraq (2003–2007)